Evidence map›Paper›PMID 35387339›Full record

ArticleFrontiers in pharmacology2022

LC-MS/MS Method for Measurement of Thiopurine Nucleotides (TN) in Erythrocytes and Association of TN Concentrations With TPMT Enzyme Activity.

Amol O Bajaj, Mark M Kushnir, Erik Kish-Trier, Rachel N Law, Lauren M Zuromski, Alejandro R Molinelli, Gwendolyn A McMillin, Kamisha L Johnson-Davis

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Pharmacogenomics · 2024
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Amol O BajajARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, United States.
Mark M KushnirARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, United States.
Erik Kish-TrierARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, United States.
Rachel N LawARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, United States.
Lauren M ZuromskiARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, United States.
Alejandro R MolinelliDepartment of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, United States.
Gwendolyn A McMillinARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, United States.
Kamisha L Johnson-DavisARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, United States.
ARUP Institute for Clinical and Experimental PathologyUniversity of Utah · USARUP Laboratories (United States) · USSt. Jude Children's Research Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Monitoring concentrations of thiopurine metabolites is used clinically to prevent adverse effects in patients on thiopurine drug therapy. We developed a LC-MS/MS method for the quantification of 6-thioguanine (6-TG) and 6-methylmercaptopurine (6-MMP) in red blood cells (RBCs). This method utilizes an automated cell washer for RBC separation from whole blood samples and washing of the separated RBCs. The lower limit of quantification of the method was 0.2 μmol/L for 6-TG (∼50 pmol/8 × 10

Indexed as

6-methylmercaptopurine6-thioguanineclinical evaluationmass spectromertythiopurine methyl transferase

Identifiers

PMID35387339
PMCPMC8978547
OpenAlexW4220774918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.